Heroin-Assisted Treatment: How It Works, Who Qualifies, and Why It’s So Controversial
You’ve probably seen the headlines. Doctors prescribing heroin. Clinics where people inject under medical supervision. It sounds shocking at first — but the reality of this treatment is more complicated, and more important, than most people realize.
Heroin-Assisted Treatment (HAT) is one of the most debated interventions in addiction medicine today. If you’re trying to understand what it actually is, whether it works, and why it remains illegal in the United States, you’re not alone. A lot of people searching for answers about opioid treatment end up with more questions than they started with. This article breaks it all down clearly.
What Is Heroin-Assisted Treatment?
Heroin-Assisted Treatment refers to the prescription of pharmaceutical heroin, also known as diacetylmorphine, to people with severe opioid use disorders who have not responded well to more traditional forms of treatment. Clients are typically provided with injectable or inhalable heroin two to three times per day by prescription, and they consume it on-site in a medically supervised clinic setting.
This is not street heroin. The substance used in HAT programs is pharmaceutical-grade, meaning its composition, dosage, and potency are controlled and consistent. The basic goal is to give people with treatment-resistant opioid use disorder a legal, regulated supply so they stop relying on the unpredictable and often deadly illicit market.
It’s worth clarifying what HAT is not. It is not the same as supervised consumption sites, where people bring their own drugs. HAT involves a clinician prescribing the substance directly.
Where Is It Used and Who Qualifies?
Heroin-Assisted Treatment is currently available in Switzerland, the Netherlands, Germany, Denmark, Belgium, and Norway. Canada has also piloted HAT programs in certain provinces.
A growing body of evidence supports the effectiveness of injectable diacetylmorphine for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll of opioid-associated morbidity and mortality, it remains controversial in some settings.
Eligibility in countries where HAT is legal typically requires:
- A documented history of severe, long-term opioid dependence
- Multiple prior failed attempts at conventional treatment
- Active, ongoing illicit heroin use despite treatment
- Age of 18 or older, in most programs
- Absence of serious medical contraindications such as certain cardiac conditions
HAT is specifically targeted at what clinicians call “treatment-refractory” patients — people for whom standard approaches simply have not worked. It is not a first-line treatment and is not intended for people early in their addiction or those who haven’t yet tried other options.
Is Heroin-Assisted Treatment Legal in the United States?
No. Heroin is a strictly regulated Schedule 1 drug in the United States, which means doctors cannot prescribe it. It is legal to conduct research on Schedule 1 drugs, but as is seen with medical marijuana research, it is a difficult process that would require approvals from several government agencies including the DEA.
This makes HAT effectively off the table for American patients right now, regardless of clinical evidence from other countries. DEA and SAMHSA govern opioid treatment regulations in the U.S., and no federal pathway currently exists for HAT outside of tightly controlled research trials.
What Does the Evidence Say?
The research on HAT outcomes is genuinely mixed, and context matters considerably.
Some findings are encouraging. Several randomized controlled trials in Canada, the United Kingdom, and the Netherlands found that people addicted to heroin benefited from the approach. They were more likely to stay in treatment compared with those who took methadone, and they were less likely to revert to using illicit heroin. Evidence also suggests that prescription heroin may be more effective than methadone in reducing criminal activity and improving patients’ physical and mental health.
Other findings raise legitimate concerns:
- HAT requires twice-daily clinic visits, which limits accessibility and creates significant logistical barriers
- Diversion risk, where prescribed substances end up on the illicit market, remains a real concern
- Programs operate under strict rules, and violations can lead to suspension or discharge
- Some reviews conclude that heroin-assisted treatment has a larger benefit-cost ratio than oral methadone because it more reliably reduces criminal activity, but the evidence base comes primarily from European and Canadian contexts that may not translate directly to the U.S.
The honest answer is that HAT helps some people who have exhausted other options. For the broader population struggling with opioid addiction, it is not a solution that’s available, legal, or appropriate.
Why Is Heroin-Assisted Treatment So Controversial?
The controversy around HAT operates on several levels simultaneously.
From a public health standpoint, critics argue that prescribing a highly addictive substance creates dependency rather than resolving it. Proponents counter that for severely dependent individuals who have failed other treatments repeatedly, managed dependency is far preferable to chaotic street use.
From a legal and regulatory standpoint in the U.S., the Schedule 1 classification of heroin creates an enormous barrier. People in focus groups and interviews expressed worry that Heroin-Assisted Treatment “would enable drug use” and face community resistance.
From a social standpoint, the concept challenges deeply held beliefs about what recovery should look like. Many in the recovery community define success as complete abstinence from all substances, while HAT operates from a harm reduction framework that prioritizes stability and safety over abstinence.
None of these concerns are trivial. They reflect real values in tension with each other, and the debate is unlikely to be resolved quickly in the United States.
What Are the Alternatives for People in Ohio?
For people in Ohio and across the U.S. who are struggling with opioid dependence, Heroin-Assisted Treatment is not currently a legal option. What is available are evidence-based treatment programs that address the full picture of addiction.
According to NIDA, effective treatments for heroin use disorder include behavioral therapies, counseling, and structured outpatient programs. These approaches work by targeting the psychological, behavioral, and social patterns that sustain addiction, not just the physical dependence.
Outpatient treatment options available in Ohio include:
- Partial Hospitalization Programs for people who need intensive, structured daily support
- Intensive Outpatient Programs for those balancing treatment with work or family obligations
- Dual Diagnosis treatment for individuals dealing with co-occurring mental health conditions like anxiety disorders, PTSD, GAD, and Panic Disorder alongside addiction
- EMDR Therapy for trauma processing, which plays a central role in many opioid use disorder cases
- Sober Living for people transitioning to independent life after structured treatment
Holistic treatment that addresses the root causes of addiction consistently produces better long-term outcomes than approaches that manage symptoms alone.
FAQs About Heroin-Assisted Treatment
1. Is heroin-assisted treatment the same as methadone treatment?
No. Methadone is a legally prescribed opioid agonist used widely in the U.S. to treat opioid use disorder. Heroin-Assisted Treatment involves prescribing pharmaceutical heroin (diacetylmorphine) directly, which is only legal in a handful of countries and is not available in the United States.
2. Does heroin-assisted treatment lead to recovery from addiction?
HAT is generally not designed to produce abstinence. Its primary goal is harm reduction: reducing overdose risk, criminal activity, and health complications for people with severe, treatment-resistant opioid dependence. Long-term recovery from addiction typically requires treatment approaches that address the behavioral and psychological roots of the disorder.
3. Which countries currently offer heroin-assisted treatment?
Switzerland pioneered HAT in the 1990s. It is currently available in Switzerland, the Netherlands, Germany, Denmark, Belgium, Norway, and parts of Canada under tightly controlled clinical conditions.
4. Can someone in Ohio access heroin-assisted treatment?
No. HAT is not legal in the United States outside of specially approved research settings, and no such programs currently exist in Ohio. People in Ohio seeking opioid addiction treatment have access to evidence-based outpatient programs, behavioral therapy, and holistic treatment options instead.
5. What treatment options exist for people who have tried other approaches and relapsed?
Multiple prior relapses do not mean treatment is hopeless. Programs like Partial Hospitalization Programs and Intensive Outpatient Programs are specifically structured for people who need more intensive support. Dual Diagnosis care is also critical for anyone whose addiction is intertwined with mental health conditions.
A More Stable, Sustainable Recovery Starts Now
The conversation around Heroin-Assisted Treatment reflects how desperate the opioid crisis has become. When people are searching for options this unconventional, it’s a sign that conventional approaches haven’t reached everyone who needs them.
At Skypoint Recovery, we believe recovery is possible — and we approach it holistically. We work with each person to figure out which program fits their situation and their life. We accept Medicaid, and we’ll help you work through your financial options from the very start.
If you or someone you care about is struggling with opioid dependence in the Akron, Ohio area, reach out today. Fill out our confidential online form or call us at 330-919-6864. We’re here to help you find the path forward.










